Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
LGBTQ Nation on MSN20h
Biden administration adds injectable PrEP requirement for insurance providersThe Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their ...
Molson Hart shared his experience of what he initially thought was a cold but which later turned out to be an infection that left him urinating blood for four days.
The Ghana AIDS Commission (GAC) says the lack of funding can impact negatively efforts to end AIDS as a public health threat ...
GlobalData on MSN1d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Health authorities in Rio de Janeiro are reviewing samples from 288 donors after discovering that two HIV-positive people ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Researchers conducted a cross-sectional analysis to evaluate bone health among menopausal women in Zimbabwe with and without human immunodeficiency virus.
On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback